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Lack of donor availability limits the number of human donor organs. The need for host immunosuppression complicates
transplantation procedures. Ultrastructurally precise kidneys diﬀerentiate in situ following xenotransplantation in mesentery
of embryonic pig renal primordia. The developing organ attracts its blood supply from the host, obviating humoral rejection.
Engraftment of pig renal primordia transplanted directly into rats requires host immune suppression. However, insulin-producing
cells originating from embryonic pig pancreas obtained very early following initiation of organogenesis [embryonic day 28
(E28)] engraft long term in nonimmune-suppressed diabetic rats or rhesus macaques. Engraftment of morphologically similar
cells originating from adult porcine islets of Langerhans (islets) occurs in rats previously transplanted with E28 pig pancreatic
primordia. Here, we review recent findings germane to xenotransplantation of pig renal or pancreatic primordia as a novel organ
replacement strategy.

1. Introduction
Transplantation of embryonic renal or pancreatic primordia
to replace the function of diseased organs oﬀers theoretical
advantages relative to transplantation of either pluripotent
ES cells or of fully diﬀerentiated (adult) organs (Reviewed
in [1, 2]). (1) Unlike embryonic stem (ES) cells, organ primordia diﬀerentiate along defined organ-committed lines.
There is no requirement to steer diﬀerentiation and no risk of
teratoma formation; (2) the growth potential of cells within
embryonic organs is enhanced relative to those in terminally
diﬀerentiated organs; (3) the cellular immune response to
transplanted primordia obtained early during embryogenesis
is attenuated relative to that directed against adult organs; (4)
early organ primordia are avascular. The ability of cellular
primordia to attract a host vasculature renders them less
susceptible to humoral rejection than are adult organs with
donor blood vessels transplanted across a discordant xenogeneic barrier; (5) organ primordia diﬀerentiate selectively.
In the case of embryonic pancreas, exocrine pancreatic tissue
does not diﬀerentiate following transplantation, obviating

complications that can result from exocrine components
such as the enzymatic autodigestion of host tissues.
While the transplantation of human embryonic organs
in human hosts has been contemplated [3–5], we [6–13] and
others [4, 5, 14–17] have focused on the use of embryonic
organs from the pig, a physiologically suitable donor for
human pancreas or kidney replacement [18, 19].

2. Xenotransplantation of
Embryonic Pig Kidney
Pig renal primordia are “preprogrammed” to diﬀerentiate
into a kidney after transplantation into the mesentery
of hosts with reduced functional renal mass (unilateral
nephrectomy). Diﬀerentiation without immune rejection
occurs following allotransplantation of embryonic day 28
(E28) pig renal primordia into mesentery of nonimmunesuppressed adult pig hosts [6]. However, engraftment and
survival of embryonic pig kidney xenografts in immunecompetent rodents require that hosts be immunosuppressed
[5, 8, 9].
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We transplanted E28 pig renal primordia (Figures 1(a)
and 1(b)) consisting of undiﬀerentiated stroma (s), branched
ureteric bud (ub), and primitive developing nephrons into
the mesentery of Lewis rats [8, 9] or C57Bl/6J mice [6].
From five to seven weeks after transplantation, no trace
of the renal primordium could be found in hosts that
received no immunosuppression. In contrast, Figure 1
illustrates undiﬀerentiated E28 pig renal primordia prior to
transplantation (Figures 1(a) and 1(b)) and diﬀerentiated
primordia 6-7 weeks after transplantation into immunesuppressed rats (Figures 1(c), 1(d), 1(e), and 1(f)). The
developed pig renal primordium is slightly larger in volume
(diameter and weight) than a normal rat kidney [8].
Although not tested following transplantation of pig
renal primordia into rats, the ultrastructurally normal
kidneys that diﬀerentiate following allotransplantation of
embryonic rat primordia are capable of filtering blood, and
urine is excreted following anastomosis between transplant
and host ureters. Such transplants support life in otherwise
anephric hosts [20, 21].
Shown in Figure 2 are glomeruli from rat kidneys
and pig kidneys and glomeruli within pig renal primordia
transplanted into rats 2 weeks previously and stained with
antirat endothelial antigen 1 (RECA-1) that is specific for
rat endothelium, or anti-CD31 that is specific for pig
endothelium. The origin of the glomerular vasculature in
transplants is rat (host). Nonglomerular renal vasculature is
also of host origin [9].
Dekel et al. successfully transplanted renal primordia
originating from pig embryos aged E20-21 to E27-28 beneath
the renal capsule of immunodeficient mice. Most transplants
from the E20–25 donors fail to develop or evolve into
growths containing few glomeruli and tubules, but other
diﬀerentiated derivatives such as blood vessels, cartilage, and
bone. In contrast, the transplants originating from E2728 pig embryos all exhibited significant growth and full
diﬀerentiation into mature glomeruli and tubule. Dekel et
al. found mouse CD31 expression in external vessels as well
as developing glomeruli and small capillaries of pig renal
primordium xenografts, consistent with a host origin for
the vasculature of the developed renal primordium cellular
transplants [5]. In addition, Dekel et al. transplanted adult
pig kidney tissue or E27-28 pig renal primordia beneath the
renal capsule or onto the testicular fat of immunocompetent
Balb/c amice. Some hosts were treated with CTLA4-Ig.
Evaluation of adult or E27-28 embryonic tissues 2 weeks
after implantation into non-CTLA4-Ig-treated hosts showed
rejection of tissues. In CTLA4-Ig-treated hosts, most E2728 renal primordia underwent growth and diﬀerentiation. In
contrast, all adult kidney grafts had a disturbed morphology,
necrotic tissue, and a high degree of lymphocyte infiltration.
The authors interpreted these data as being consistent
with an immune advantage of the developing precursor
transplants over developed adult kidney transplants in fully
immunocompetent hosts [5].
Dekel and coworkers implanted metanephroi from E70
human embryos intraperitoneally into immunodeficient
(SCID) mice. Transplanted kidneys survived for more than
2 months after transplantation [4]. Hybridization to cDNA
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arrays of RNA derived from normal human renal primordia
at 8, 12, 16, or 20 weeks of gestation demonstrated a subset
of 240 genes, the expressions of which changed substantially
with time. Clustering analysis of global gene expression in
transplants after transplantation revealed a temporal profile
of gene expression similar to that observed in the normal
human kidneys during development, consistent with recapitulation of a renal developmental program. Comparison
of the expression profiles of developing metanephroi to a
Wilms’ tumor specimen revealed no similarity consistent
with no threat of malignant transformation after transplantation of human kidney precursors.

3. Xenotransplantation of
Embryonic Pig Pancreas
We have shown that glucose tolerance can be normalized in
streptozotocin- (STZ-) diabetic (type 1) LEW [7, 8, 12] rats
or ZDF (type 2) diabetic rats [10] within 4 weeks following
transplantation in mesentery of pig pancreatic primordia
obtained very early during embryogenesis (on embryonic
day 28 (E28)—just after the organ diﬀerentiates and prior
to the time dorsal and ventral anlagen fuse) without
host immune suppression. Rats are rendered permanently
independent of a requirement for exogenous insulin to
maintain normoglycemia. No circulating rat insulin can be
detected in STZ-treated rats. Porcine insulin circulates after
transplantation of E28 pig pancreatic primordia (embryonic
pancreas), and levels increase after a glucose load. Cells
expressing insulin and porcine proinsulin mRNA with beta
cell morphology engraft in host mesentery, mesenteric
lymph nodes, liver, and pancreas after transplantation.
Cells originating from E28 pig pancreatic primordia engraft
similarly in nonimmune-suppressed STZ-diabetic rhesus
macaques [11].
Figure 3 shows photomicrographs originating from a
mesenteric lymph node of a transplanted rhesus macaque.
Sections in Figures 3(a), 3(c), and 3(e) are stained with an
anti-insulin antibody. Sections in Figures 3(b), 3(d), and
3(f) are incubated with control serum. Sections of medullary
sinus are delineated by arrows (Figures 3(a), 3(b), 3(c), and
3(d)). Individual cells with beta cell morphology that stain
positive (red) are delineated by arrowheads (Figure 3(e)).
No positive-staining cells are found in sections treated
with control serum (Figures 3(b), 3(d), and 3(f). Cells
with morphology similar to positive cells in Figure 3(e)
are delineated in Figure 3(f) (arrowheads). No insulinpositive cells are present in mesenteric lymph nodes of
nontransplanted rhesus macaques [11].
As shown in Figure 4, glucose tolerance can be
nearly normalized in nonimmune-suppressed diabetic rhesus macaques following transplantation of E28 pig pancreatic
primordia [13]. Exogenous insulin requirements are reduced
in transplanted macaques [11], and animals have been
weaned oﬀ insulin for short periods of time, but not
permanently. The most likely explanation for the diﬀerence
between rats and macaques is that macaques weigh 20
times as much as rats. An STZ-diabetic rat can be rendered
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Figure 1: Photographs (a, c, d) and photomicrographs (b, e, f) of E28 pig renal primordia (a, b) or E28 pig renal primordia 7 weeks after
transplantation into the mesentery of a rat (c–f). (a) E28 primordium (ub, ureteric bud); (b) E28 primordium (s, stroma; ub, ureteric
bud); (c) E28 pig renal primordium 7 weeks after transplantation in a rat mesentery; (d) E28 pig renal primordium after removal from the
mesentery (u, ureter), (e) Cortex with a glomerulus, (g) proximal tubule (pt), and distal tubule (dt) labeled; (f) Medulla with collecting duct
(cd) labeled. Magnifications are shown for (a) and (b) (in (a)); (c) and (d) (in (d)); (e) and (f) (in (e)) reproduced with permission [8].

normoglycemic lifelong with no exogenous insulin requirement by transplantation of 5–8 pig pancreatic primordia.
Extrapolating, it would take 100–160 primordia to render a
diabetic rhesus macaque independent of exogenous insulin.
This would require the sacrifice of about 7–12 pregnant sows
and multiple surgeries [12] with the attendant complications.
In lieu of increasing the number of transplanted primordia in diabetic rhesus macaques, we embarked on a
series of experiments to determine whether porcine islets,
a more easily obtainable and possibly more robust source
of insulin-producing cells, could be substituted in animals
rendered tolerant to embryonic pig pancreas. Our first step
was to determine using rats, whether engraftment of cells
originating from E28 pig pancreatic primordia renders hosts
tolerant to the same or similar cell component present in
porcine islets from adult swine (adult islets). To this end,
we implanted adult porcine islets beneath the renal capsule

of rats that previously had been transplanted with E28 pig
pancreatic primordia in mesentery [12].
Figure 5 shows sections from a kidney from an STZdiabetic rat transplanted previously with embryonic pig
pancreas in mesentery and subsequently with pig islets in
one kidney. Sections are stained using anti-insulin antibodies
(Figures 5(a) and 5(c)) or control serum (Figures 5(b) and
5(d)). As would be expected for kidney that filters, reabsorbs,
and secretes insulin, proximal tubules (PTs) in Figure 5(a)
are positive (red brown) relative to comparable structures
in Figure 5(b). Cells that stain for insulin (Figure 5(a)),
but not with control serum (Figure 5(b)) are present in
an expanded subcapsular space (Figures 5(a) and 5(b);
arrowheads). Figure 5(c) shows a higher magnification of the
subcapsular space. The cells that stain positive for insulin
(red-brown stain) are polygonal with round nuclei and
abundant cytoplasm (arrow), a beta cell morphology. Also
shown in Figure 5 are sections incubated with antisense
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Figure 2: Photomicrographs of stained sections of (a, c) rat kidney; (b, d) pig kidney; (e, f) a pig renal primordium from an E28 embryo 8
weeks after transplantation into a rat mesentery, stained with RECA-1 (a, b, e) or CD31 (c, d, f). Glomerular capillaries in transplants stain
positive for RECA-1 that is specific for rat endothelium (e) and negative for CD31 that is specific for pig endothelium (f). Magnifications
are shown for (a–d) (in (a)) and (e) and (f) (in (e)), reproduced with permission [9].

(Figure 5(e)) or sense (Figure 5(f)) porcine proinsulin
mRNA probes. Hybridization occurs following incubation
with the former (arrows), but not the latter. In contrast to the
transplanted kidney, there is no expansion of the subcapsular
space in the contralateral (nontransplanted) kidney and no
cells are present with beta cell morphology. The subcapsular
space of a kidney from a rat implanted with porcine islets
four weeks previously with no prior transplantation of E28
pig pancreatic primordia is expanded relative to that of a
nontransplanted kidney. However, there are no cells with
beta cell morphology that stain for insulin [12].
Schroeder et al. [22] define transplantation tolerance
as immune unresponsiveness to the transplanted organ,
but not to other antigens, in the absence of ongoing

immunosuppression. LEW rats transplanted with E28 pig
pancreatic primordia retain reactivity to other porcine
xenoantigens (E28 pig renal primordia are rejected) [8].
Thus, our findings are consistent with induction of specific
tolerance [22] to a cell component (either beta cells or a stem
cell component that diﬀerentiates into insulin-producing
cells) of adult porcine islets implanted in LEW rats by
previous transplantation of E28 pig pancreatic primordia.
Though not observed following xenotransplantation
under all conditions [16, 17], host tolerance to early stage
pancreatic progenitors has been reported twice previously.
Eloy et al. described normalization of glucose after transplantation of E15, but not E18 embryonic chick pancreas into
non-immune-suppressed STZ-diabetic immune-competent
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Figure 3: Photomicrographs of mesenteric lymph node from an STZ-diabetic rhesus macaque, 78 days after transplantation of E28 pig
pancreatic primordia. Sections (a), (c), and (e) are stained with an anti-insulin antibody. Sections (b), (e), and (f) are stained using a control
serum. Sections of medullary sinus are delineated by arrows (a–d). Individual cells with beta cell morphology are delineated by arrowheads
(e) and (f). Scale bars 120 um (a) and (b); 80 um (c) and (d); 20 um (e) and (f), reproduced with permission [11].

rats [23]. Abraham et al. [24] described successful xenoengraftment in multiple organs of human pancreatic isletderived progenitor cells infused in nonimmunosuppressed
immune-competent mice. It is possible that xenotransplantation of fetal pancreas is particularly suited to induction of
tolerance. However, neither Eloy et al. [23], nor Abraham
et al. [24], nor we [7, 8, 10–12] define an immunological
mechanism.
Although the antigenicity of fetal tissues may be less
than that of corresponding adult tissues, animal data suggest
the reduction is not enough by itself to ensure permanent
graft survival [25]. Thus, the use of embryonic tissue
(pancreas) per se cannot explain our findings. Host immune
suppression is required for successful engraftment of embryonic pig pancreas in rodents [16] or nonhuman primates
[17] carried out using methodology diﬀerent from ours.
Therefore, it is likely that one or more diﬀerential factors
in the methodology we employ are critical for engraftment

of embryonic pig pancreas without an immune suppression
requirement. Such factors could include the developmental
stage of embryos from which primordia are obtained, the
number of pancreatic primordia transplanted, the manner
in which embryonic pancreas organs are incubated in vitro
prior to implantation, the diabetic status of the host,
the transplantation site and methodology for securing the
implants in place, and the stringency by which glucose levels
in diabetic hosts are controlled after transplantation [13].
We have proposed [13] that transplantation of E28 pig
pancreatic primordia in the mesentery and migration of cells
to mesenteric lymph nodes and liver recapitulates events that
occur during induction of oral tolerance [26–28], the induction of which is dependent on antigen transport via aﬀerent lymphatics into the draining mesenteric lymph nodes
[28]. In eﬀect, we suggest that heterotopic introduction of
embryonic pig pancreas in rat or primate mesentery co-opts
the function of the gut-associated lymphoid tissues (GALT),
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Figure 4: Intravenous glucose tolerance in rhesus macaques. Glucose in peripheral venous blood was measured prior to intravenous
infusion of dextrose (Time 0) and at several times after infusion
in three fasted rhesus macaques either prior to administration of
STZ (Pre-STZ), 5 days following administration of STZ (Post-STZ),
or 3 months following transplantation of 20–40 E28 pig pancreatic
primordia in mesentery of STZ-diabetic macaques (Post-TX). Data
are shown as mean ± SE (3 macaques), reproduced with permission
[13].

a complex redundant [26–28] and phylogenetically ancient
system [29, 30] of which embryonic pancreas is a part [31],
that under normal conditions induces peripheral tolerance to
ingested antigens in jawed vertebrates and their descendants.
Harada et al. have proposed a similar co-opting of oral
tolerance to explain the muted immune response in vivo and
by cells from mesenteric lymph nodes in vitro to a colon
carcinoma of BALB/c origin or a human CD80-transfected
DBA/2 mastocytoma injected into the subserosa of cecum
in BALB/c mice relative to tumors injected subcutaneously
[32]. GALT may have served similarly to prevent an immune
response to insulin-producing cells scattered originally in the
gut epithelium of primitive vertebrates [29, 30] and have
been proposed to induce tolerance or immune suppression
towards islet cell antigens during normal embryonic development [31].

4. Perspectives
Dialysis as a therapy for end-stage kidney failure is life
preserving but replaces only a small fraction of normal
kidney function and has and considerable morbidity. Kidney
allotransplantation provides a higher level of renal function
and a less constrained lifestyle. However, it is limited by the
number of human organs available [33].

Use of oral hypoglycemic agents and administration of
insulin are cornerstones of treatment for diabetes mellitus.
However, adequate control of circulating glucose levels
cannot be attained by most patients, and attempts at
maintaining euglycemia through intensive insulin therapy
lead to hypoglycemia. In contrast, allotransplantation therapies (whole pancreas or islets of Langerhans (islets)) can
normalize glucose control [1, 2]. Given existing technology,
a major limitation to the use of either whole pancreas or
islet allotransplantation is the insuﬃcient supply of human
organs. Compounding this limitation for islet transplantation is the need to transplant large quantities of islets
from multiple donors to achieve even short-term insulin
suﬃciency. Selection criteria at most US centers for pancreas
transplantation dictate a conservative approach that excludes
most type 2 diabetics, traditionally older and poorer surgical
risks than type 1 patients.
Whole pancreas transplantation requires use of potent
immunosuppressive medications that have significant complications. Newer, more targeted immunosuppressive regimens that do not require steroid or high-dose calcineurin
inhibitors make islet transplantation a more attractive
option. However, side eﬀects of immune suppression that
must be maintained so long as the graft functions remain
a source of morbidity and even mortality [34]. Thus, transplantation therapy for diabetes trades one set of morbidities
(associated with diabetes and its medical treatment) for
another (associated with immune suppression).
In that pigs are plentiful and have renal function very
similar to humans, and because porcine insulin works well in
humans, the pig has been suggested as a kidney or pancreas
organ donor for humans with chronic kidney disease or
diabetes. While humoral rejection is ameliorated following
transplantation into nonhuman primates of kidneys from
pigs transgenic for the human complement activator, decay
accelerating factor [35], or the use of kidneys or organs
from transgenics that do not express alpha 1,3 galactosyltransferase [36], neither the immunosuppressive regimens
used for pig to primate kidney transplantation nor the
outcomes would be acceptable in humans. The severity of
humoral rejection eﬀectively precludes the use of pigs as
whole pancreas organ donors for humans. However, because
they are vascularized by the host after transplantation,
islets like other cell transplants are not subject to humoral
rejection. Recent experience with pig to primate islet or
neonatal islet transplantation shows that sustained insulin
independence can be achieved, but only through the use of
immunosuppressive agents that are not approved for human
use or that result in a high level of morbidity and mortality in
diabetic primates [37–39]. Thus, the need for host immune
suppression is a barrier for pig-to-primate kidney or islet
xenotransplantation.
The use of individual cells including stem cells to regenerate or repair damaged kidney tissue or diﬀerentiate into
insulin-producing cells (cell therapies) oﬀers an alternative
to whole organ replacement. Since cells are nonvascularized, these approaches can circumvent humoral rejection
of xenogeneic tissue mediated by preformed antibodies
directed against donor endothelial antigens. However, cell
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Figure 5: Photomicrographs of kidney from a diabetic rat into which embryonic pig pancreas had been transplanted in mesentery, and
pig islets had been transplanted subsequently in kidney stained using anti-insulin antibody (a, c) or control antibody (b, d) and sections
hybridized to antisense (e) or sense (f) porcine proinsulin mRNA probes. Arrowheads delineate an expanded subcapsular space (a, b).
Arrows delineate tissue in the subcapsular space that stains positive for insulin (red-brown) (c) or positive staining for porcine proinsulin
mRNA (e). PT, proximal tubule (a, b). Scale bars 80 um (a, b) and 10 um (c–f), reproduced with permission from the American Society for
Investigative Pathology [12].

transplantation to replace the function of a structurally
complex organs such as the kidney has limitations. In order
for glomerular filtration, reabsorption, and secretion of
fluid and electrolytes to take place in a manner that will

sustain life, individual nephrons must be integrated in three
dimensions with one another and with a collecting system,
the origin of which is yet another separate structure, the
ureteric bud. Concomitantly, vascularization must occur in
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a unique organ-specific manner from endothelial precursors
that may originate from both inside and outside of the
developing renal primordium. While it is conceivable that
endocrine functions of the kidney, such as erythropoietin
production, could be recapitulated by transplanting one
particular type of renal cell and it is possible that replacement
of one or another type of injured renal cell could enhance
the function of damaged tubules, it is diﬃcult to imagine
how glomerular filtration and reabsorption in kidneys could
be reconstituted de novo by infusion of individual cells
[33]. Recent studies have generated pancreatic cells from
human ES cells. However, successful diﬀerentiation in vitro
of functional beta cells remains an elusive goal [40].
Xenotransplantation of embryonic pig renal or pancreatic primordia in lieu of mature pig organs or porcine
islets couples the wide availability of whole pig organs with
the immunological advantages inherent in transplanting
cellular embryonic tissue, circumventing humoral rejection,
and in the case of pancreas, obviating the need for host
immune suppression. Furthermore, unlike ES cells, renal and
pancreatic primordia are programmed to diﬀerentiate into
anatomically precise kidneys or beta cells in which glucose
sensing and insulin release are functionally linked. Finally,
prior transplantation of pig pancreatic primordia permits
the engraftment of an insulin-producing cell component
originating from porcine islets implanted subsequently.
Xenotransplantation of embryonic pig kidney or pancreas, once employed safely and eﬀectively in humans, will
provide in essence an unlimited supply of donor organs. This
will result in a paradigm shift in how the world thinks about
organ replacement: (1) there will be no need to transport
organs across long distances; (2) transplantation can be
done electively at a convenient time; (3) transplantation
can be oﬀered to high-risk individuals and can be repeated
as needed; (4) transplantation can be oﬀered to patients
currently not candidates including type 2 diabetics.
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